Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PYRROLOPYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/258044
Kind Code:
A1
Abstract:
Provided are a pyrrolopyridinone compound as represented by formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutical preparation, a pharmaceutical composition and the use of the compound, wherein the compound can be used for the preparation of drugs for treating or preventing diseases related to and mediated by MAP4K1.

More Like This:
JP2018012734OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
WO/2003/078423COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES
JP2008534496A novel tetrahydro-1H-pyrido [4,3-b] indole derivative as a CB1'receptor ligand
Inventors:
ZHAI WENQIANG (CN)
ZHANG ZHIMIN (CN)
GUO LIUBIN (CN)
PAN HAO (CN)
WANG ZHE (CN)
XIA YAN (CN)
LIU DONGZHOU (CN)
Application Number:
PCT/CN2022/098098
Publication Date:
December 15, 2022
Filing Date:
June 10, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D471/04; A61K31/437; A61P35/00; C07D519/00
Domestic Patent References:
WO2020092528A12020-05-07
WO2020092621A12020-05-07
WO2013097601A12013-07-04
Foreign References:
US20200172539A12020-06-04
CN110402248A2019-11-01
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: GEMCITABINE ANTICANCER DERIVATIVE AND ANTICANCER PHARMACEUTICAL USE

Next Patent: BIFUNCTIONAL FUSION PROTEIN MOLECULE CONTAINING ANTI-HUMAN IL-17 ANTIBODY AND TACI